Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 1998, p. 1646-1653, Vol. 42, No. 7
Division of Pharmaceutics and
Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University
of British Columbia, Vancouver, British Columbia,
Canada1;
ZymeTx, Inc., Oklahoma
City, Oklahoma2; and
Aronex
Pharmaceuticals, Inc., The Woodlands, Texas3
Received 16 December 1997/Returned for modification 22 March
1998/Accepted 27 April 1998
The objective of the proposed study was to determine the
distribution in plasma lipoprotein of free all-trans
retinoic acid (ATRA) and liposomal ATRA (Atragen; composed of
dimyristoyl phosphatidylcholine and soybean oil) following incubation
in human, rat, and dog plasma. When ATRA and Atragen at concentrations
of 1, 5, 10, and 25 µg/ml were incubated in human and rat plasma for
5, 60, and 180 min, the majority of the tretinoin was recovered in the
lipoprotein-deficient plasma fraction. However, when ATRA and Atragen
were incubated in dog plasma, the majority of the tretinoin (>40%)
was recovered in the high-density lipoprotein (HDL) fraction. No
differences in the plasma distribution between ATRA and Atragen were
found. These data suggest that a significant percentage of tretinoin associates with plasma lipoproteins (primarily the HDL fraction) upon
incubation in human, dog, and rat plasma. Differences between the
lipoprotein lipid and protein profiles in human plasma and in dog and
rat plasma influenced the plasma distribution of ATRA and Atragen.
Differences in lipoprotein distribution between ATRA and Atragen were
not observed, suggesting that the drug's distribution in plasma is not
influenced by its incorporation into these liposomes.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Differences in the Lipoprotein Distribution of Free and
Liposome-Associated All-trans-Retinoic Acid in Human,
Dog, and Rat Plasma Are Due to Variations in Lipoprotein Lipid and
Protein Content
*
Corresponding author. Mailing address: Division of
Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada
V6T 1Z3. Phone: (604) 822-4889. Fax: (604) 822-3035. E-mail: Kwasan{at}unixg.ubc.ca.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |